17-63704443-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_001003787.4(STRADA):​c.998G>C​(p.Arg333Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,300 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R333W) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

STRADA
NM_001003787.4 missense

Scores

7
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.33

Publications

0 publications found
Variant links:
Genes affected
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
STRADA Gene-Disease associations (from GenCC):
  • polyhydramnios, megalencephaly, and symptomatic epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRADANM_001003787.4 linkc.998G>C p.Arg333Pro missense_variant Exon 11 of 13 ENST00000336174.12 NP_001003787.1 Q7RTN6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRADAENST00000336174.12 linkc.998G>C p.Arg333Pro missense_variant Exon 11 of 13 1 NM_001003787.4 ENSP00000336655.6 Q7RTN6-1
ENSG00000125695ENST00000580553.1 linkn.*912G>C non_coding_transcript_exon_variant Exon 10 of 12 5 ENSP00000464100.1 J3QR89
ENSG00000125695ENST00000580553.1 linkn.*912G>C 3_prime_UTR_variant Exon 10 of 12 5 ENSP00000464100.1 J3QR89

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1459300
Hom.:
0
Cov.:
45
AF XY:
0.00000138
AC XY:
1
AN XY:
725734
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33466
American (AMR)
AF:
0.00
AC:
0
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86168
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52136
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5740
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111062
Other (OTH)
AF:
0.00
AC:
0
AN:
60280
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Uncertain
-0.020
CADD
Uncertain
25
DANN
Benign
0.93
DEOGEN2
Benign
0.067
.;.;T;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
D;.;D;D;.;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.036
D
MetaRNN
Uncertain
0.52
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.2
.;.;L;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
7.3
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.3
.;.;N;.;N;.;.;N;N;.;.;.;.;.;.
REVEL
Benign
0.25
Sift
Benign
0.050
.;.;D;.;D;.;.;T;D;.;.;.;.;.;.
Sift4G
Benign
0.18
.;.;T;.;T;.;.;T;T;.;.;.;.;T;.
Polyphen
0.99, 0.99, 0.99
.;D;D;D;.;.;.;.;D;.;.;.;.;.;.
Vest4
0.68, 0.69, 0.63, 0.61, 0.75
MutPred
0.46
.;.;Gain of glycosylation at R333 (P = 0.0075);.;.;.;.;.;.;.;.;Gain of glycosylation at R333 (P = 0.0075);Gain of glycosylation at R333 (P = 0.0075);.;.;
MVP
0.78
MPC
1.5
ClinPred
0.91
D
GERP RS
4.9
PromoterAI
0.12
Neutral
Varity_R
0.79
gMVP
0.61
Mutation Taster
=19/81
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs754413346; hg19: chr17-61781803; API